Skip to content
Information for Patients

Information for HCPs

The ENERGIZE Clinical Trials

Now Enrolling Adult Patients With Thalassemia

ENERGIZE, for adult patients with non–transfusion-dependent alpha- or beta-thalassemia (5 transfusions about every 6 months):

Learn about ENERGIZE

ENERGIZE-T, for adult patients with transfusion-dependent alpha- or beta-thalassemia (6 transfusions about every 6 months):

Learn about ENERGIZE-T

Mitapivat is not approved by health authorities for the treatment of thalassemia.